SCHEMBL20193227

SCHEMBL20193227

COC1=C(OC)C(=O)C(C(C)C=C(C)C)=C(C)C1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APEX1 P27695 9/20 0.42
IDO1 P14902 2/20 0.40
LMNA P02545 3/20 0.38
CDC25A P30304 2/20 0.35
CDC25B P30305 2/20 0.35
MAPT P10636 3/20 0.35
TDP1 Q9NUW8 3/20 0.35
CYP3A4 P08684 2/20 0.35
CYP2D6 P10635 2/20 0.35
CYP2C9 P11712 2/20 0.35
CYP2C19 P33261 2/20 0.35
PGR P06401 1/20 0.35
MAOA P21397 1/20 0.35
TBXA2R P21731 1/20 0.35
MAPK1 P28482 1/20 0.35
AVPR2 P30518 1/20 0.35
HTR2B P41595 1/20 0.35
HTT P42858 1/20 0.35
PDE3A Q14432 1/20 0.35
SIRT2 Q8IXJ6 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22449556 0.76 CDC25A (0.38) APEX1IDO1LMNACDC25ACDC25B
SCHEMBL8248751 0.75 IDO1 (0.48) APEX1IDO1LMNACDC25ACDC25B
SCHEMBL8368999 0.71 IDO1 (0.44) APEX1IDO1LMNACDC25ACDC25B
SCHEMBL22882763 0.69 IDO1 (0.44) APEX1IDO1LMNACDC25ACDC25B
SCHEMBL13227495 0.68 APEX1 (0.68) APEX1IDO1LMNACDC25ACDC25B
SCHEMBL13479450 0.68 IDO1 (0.40) APEX1IDO1LMNAMAPTTDP1
Aurantiogliocladin SCHEMBL487583 0.67 MAPT (0.50) APEX1IDO1LMNACDC25ACDC25B
SCHEMBL5455307 0.67 CDC25A (0.48) APEX1IDO1LMNACDC25ACDC25B
SCHEMBL15944061 0.66 CDC25A (0.52) APEX1IDO1LMNACDC25ACDC25B
SCHEMBL6577669 0.66 IDO1 (0.37) APEX1IDO1LMNACDC25ACDC25B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9982009-B2 Methods for treating polycystic kidney disease and polycystic liver disease MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2018-05-29 US disclosed